Is Klebsiella Aerobic or Anaerobic?

Klebsiella is a facultative anaerobe, meaning it thrives in the presence of oxygen but can also grow and reproduce without it. This metabolic flexibility is one of the defining features of the genus and a major reason Klebsiella species turn up in such a wide range of environments, from well-aerated soils and water surfaces to the deep, nearly oxygen-free interior of the human gut. The distinction matters clinically, ecologically, and industrially, because the bacterium’s behavior changes significantly depending on how much oxygen is available.

What “Facultative Anaerobe” Actually Means

Bacteria fall along a spectrum when it comes to oxygen. Strict aerobes die without it. Strict anaerobes are poisoned by it. Facultative anaerobes sit comfortably in the middle: they prefer oxygen when it is around because aerobic respiration extracts far more energy per molecule of fuel, but they switch to fermentation or alternative electron acceptors when oxygen runs low. Klebsiella pneumoniae, the most clinically studied species in the genus, fits squarely in this category and has been repeatedly described as a gram-negative facultative anaerobic bacterium in research spanning decades.¹ The same holds for other species in the genus, including Klebsiella oxytoca, which has been isolated from environments where oxygen supply fluctuates widely.²

This dual capability is not just a laboratory curiosity. In a living host, oxygen levels vary dramatically from one tissue to the next. The bloodstream is well-oxygenated, the interior of a liver abscess is not, and the colon sits somewhere near the far low end. A bacterium that can operate across that entire range has a colonization advantage that strict aerobes and strict anaerobes simply lack.

How Klebsiella Uses Oxygen When It Is Available

When oxygen is present, Klebsiella species run a full aerobic respiratory chain, using oxygen as the final electron acceptor to generate energy efficiently. Like other members of the Enterobacteriaceae family, Klebsiella pneumoniae produces multiple terminal oxidases, the enzymes at the end of the respiratory chain that hand electrons off to oxygen. Research has identified at least two distinct terminal oxidases in K. pneumoniae, including a cytochrome bd-type oxidase that appears to play a role in scavenging oxygen during microaerobic conditions and helping supply energy for other metabolic processes.³

Klebsiella oxytoca shows a similar arrangement. Studies of a cyanide-resistant strain revealed two terminal oxidases, cytochrome d and cytochrome o, each with different sensitivities to inhibition. When environmental conditions change, the bacterium adjusts which oxidase it favors, ramping up expression of the more resistant form when needed.⁴ This ability to swap between respiratory enzymes gives the organism a kind of biochemical contingency plan: if one pathway is compromised, another can pick up the slack.

Life Without Oxygen and the Fermentation Products That Result

Strip away oxygen, and Klebsiella does not simply stop growing. It shifts to fermentation, breaking down sugars and other carbon sources through pathways that do not require an external electron acceptor. The end products of that fermentation are diverse and, as it turns out, commercially interesting. K. pneumoniae can convert glycerol into compounds like 1,3-propanediol, 2,3-butanediol, lactic acid, ethanol, and succinic acid under anaerobic conditions.¹

2,3-butanediol has attracted particular attention. It serves as a building block for synthetic rubbers, plastics, and solvents, making it a potential bio-based alternative to petroleum-derived chemicals. Researchers have genetically engineered both K. pneumoniae and K. oxytoca to boost production of this compound. In one study, a rationally engineered K. pneumoniae strain achieved a 2,3-butanediol yield of about 0.46 grams per gram of glucose consumed, roughly 92% of the theoretical maximum, with far fewer unwanted by-products than the wild-type strain.⁵ A separately engineered K. oxytoca mutant managed to produce 115 grams per liter of 2,3-butanediol in fed-batch fermentation, a concentration high enough to be industrially relevant.²

The metabolic flexibility here is key. K. pneumoniae can use the same carbon source, glycerol for instance, under either aerobic or anaerobic conditions and route it toward different end products depending on what the cell needs. That versatility is what makes the organism attractive as a potential microbial factory, though its pathogenic potential obviously complicates any industrial use.

Nitrogen Fixation and Why It Demands Low Oxygen

One of the more remarkable things Klebsiella can do is fix atmospheric nitrogen, converting N₂ gas into ammonia that living things can actually use. This is the same fundamental reaction carried out by the nitrogen-fixing bacteria that live in the root nodules of legumes, and it is ecologically important because it adds biologically available nitrogen to ecosystems. Klebsiella pneumoniae was one of the first organisms in which the genetics of nitrogen fixation were thoroughly mapped, partly because it is so much easier to grow and manipulate in the lab than many other nitrogen-fixing species.

Here is the catch: the nitrogenase enzyme that carries out this reaction is irreversibly destroyed by oxygen. Even brief exposure to aerobic conditions ruins both protein components of the enzyme complex.⁶ So a bacterium that normally tolerates and benefits from oxygen has to solve a tricky problem: how do you fix nitrogen when the very air you breathe wrecks your enzyme?

Klebsiella’s answer is regulatory rather than structural. It does not build an oxygen-barrier compartment the way some cyanobacteria do. Instead, it simply shuts off nitrogenase gene expression when oxygen is present. The system works through a pair of regulatory proteins, NifL and NifA. NifL acts as an oxygen sensor: in its oxidized state it locks up NifA, preventing it from activating the genes for nitrogenase. Only when oxygen drops low enough for NifL to become reduced does NifA get released and switch on nitrogen fixation.⁷ The sensing mechanism depends on the cell’s internal redox state, effectively using the respiratory chain as a proxy for external oxygen levels.⁸

In nature, this means Klebsiella fixes nitrogen only in low-oxygen niches. One well-documented example is the hindgut of the Formosan subterranean termite, where K. pneumoniae was isolated as a nitrogen-fixing resident of the gut community.⁹ The termite gut is largely anaerobic, which solves the oxygen problem for nitrogenase and allows the bacterium to supply its host with a nutrient the insect cannot produce on its own.

What Happens Inside Biofilms

In clinical settings, Klebsiella commonly forms biofilms on surfaces like catheters, ventilator tubing, and wound sites. A biofilm is essentially a microbial city enclosed in a self-produced matrix of sugars and proteins. One important characteristic of mature biofilms is that they create their own oxygen gradient. Bacteria at the outer surface consume oxygen through normal respiration, and the dense matrix restricts fresh oxygen from diffusing inward. The result is a hypoxic, sometimes nearly anaerobic, core deep inside the biofilm.¹⁰

For a facultative anaerobe like Klebsiella, this gradient is almost tailor-made. Surface cells can respire aerobically and grow quickly, while cells in the interior shift to fermentative metabolism and often enter a slower-growing, more stress-tolerant state. That metabolic heterogeneity is one reason biofilm infections are so difficult to treat. Many antibiotics work best on actively dividing cells, and the slow-growing interior cells are partially shielded both physically and metabolically. Researchers have begun designing nanoparticles that exploit the hypoxic biofilm interior, releasing their antibiotic payload only when oxygen drops low enough, an approach specifically aimed at reaching the cells that conventional drugs miss.

Defending Against Oxygen’s Toxic Side

Oxygen is not purely beneficial even for organisms that use it. Normal aerobic metabolism inevitably generates reactive oxygen species, molecules like hydrogen peroxide that can damage DNA, proteins, and membranes. In infection, the problem intensifies: the host immune system deliberately bombards invading bacteria with reactive oxygen species as a killing mechanism.

Klebsiella has evolved dedicated defenses. Recent research has highlighted the role of cytochrome bd-II oxidase, encoded by the CyxA gene, in protecting K. pneumoniae from oxidative stress. This enzyme appears to help the bacterium cope with hydrogen peroxide and the oxidative burst it faces during inflammation and elevated temperatures. Strains with a functional CyxA showed enhanced growth and virulence under oxidative conditions, and the effect was linked to the enzyme’s ability to metabolize hydrogen peroxide either directly or through downstream pathways.¹¹ In other words, a protein originally evolved for respiration has been co-opted into a virulence tool: it helps the bacterium survive the immune system’s oxygen-based weapons.

How Oxygen Levels Shape Iron Acquisition

Iron is essential for virtually all bacteria, and Klebsiella is no exception. But the form iron takes depends heavily on oxygen. In oxygen-rich environments, iron is mostly in its insoluble ferric form, locked away and hard to grab. In low-oxygen or anaerobic settings, iron shifts to its soluble ferrous form, which is much easier for cells to import. Enterobacteriaceae, including Klebsiella, have evolved separate iron-uptake systems for each condition, and they toggle between them using global oxygen-sensing regulators called ArcA and Fnr.¹²

This matters during infection. When K. pneumoniae invades airway cells, the host responds by adjusting its own iron handling. Infected cells upregulate ferroportin, an iron exporter, essentially pushing iron out of the cell. This pattern differs from the response to some other Enterobacteriaceae and appears linked to the oxidative stress K. pneumoniae induces inside host cells.¹² The interplay between oxygen status, iron availability, and immune evasion is one of those areas where Klebsiella’s facultative lifestyle feeds directly into its ability to cause disease.

Blooming in the Gut

The human colon is one of the most oxygen-poor environments in the body, dominated by strict anaerobes. Klebsiella normally exists there at low numbers, held in check by the resident anaerobic community. But disruptions to that community can open the door to dramatic Klebsiella expansion. In mouse experiments, systemic exposure to bacterial lipopolysaccharide triggered a roughly thousand-fold bloom of K. pneumoniae in the gut within 24 hours, driven in part by reactive oxygen species that harmed the competing anaerobic bacteria more than the oxygen-tolerant Klebsiella.¹³

This is a practical illustration of why the aerobic-anaerobic distinction matters clinically. The same metabolic flexibility that lets Klebsiella survive in a low-oxygen gut also lets it outcompete strict anaerobes when oxidative stress reshuffles the microbial landscape. Inflammation, antibiotic use, and immune suppression can all shift the gut toward conditions that favor facultative anaerobes over the strict anaerobes that usually dominate. Klebsiella is well positioned to exploit every one of those shifts.

Industrial Fermentation and Why Oxygen Control Matters

Biotechnology researchers have spent considerable effort tuning the oxygen environment in Klebsiella fermentations to steer the organism toward desired products. One example is the production of 1,3-propanediol, a compound used in manufacturing polymers and cosmetics. Conventional fermentation of this compound demands strictly anaerobic conditions, which are expensive to maintain at scale. However, a strain of K. pneumoniae screened from the ATCC 25955 line turned out to be relatively insensitive to oxygen, allowing researchers to run a milder, partially aerobic process that was simpler and cheaper to operate.¹⁴

More recently, CRISPR-based genetic engineering has pushed yields further. An engineered K. pneumoniae strain produced about 58 grams per liter of 1,3-propanediol in a 7.5-liter fermentation tank, roughly a quarter more than the unmodified parent strain.¹⁵ The ability to manipulate how Klebsiella handles oxygen gives engineers an extra lever: they can fine-tune aeration to push metabolic flux toward the product they want while suppressing unwanted by-products.

The tension throughout all of this work is that K. pneumoniae is a human pathogen. Using it in industrial fermentation carries biosafety concerns that do not apply to organisms like baker’s yeast. Some researchers have addressed this by engineering out virulence factors alongside boosting production. Others have shifted attention to K. oxytoca strains that are naturally less pathogenic while retaining similar metabolic capabilities. Either way, the underlying metabolic versatility, rooted in that same facultative anaerobe physiology, is what makes Klebsiella appealing in the first place.

Abscess Formation and Deep-Tissue Infections

Klebsiella pneumoniae is one of the leading causes of pyogenic liver abscess, particularly in East and Southeast Asia. Inside an abscess cavity, conditions are harsh: oxygen is scarce, the pH is low, and the immune system is walled off by fibrous tissue. For a strictly aerobic bacterium, this would be a dead end. For a facultative anaerobe, it is just another niche to colonize. The bacteria in the abscess core can ferment their way through the low-oxygen interior while cells at the abscess margin, which have slightly better blood supply, may still engage in aerobic respiration.

Treatment is complicated by the same oxygen gradient. Antibiotics reach abscess cavities poorly, and the metabolic state of the bacteria inside affects which drugs work. Slow-growing, fermenting cells deep in an abscess respond differently to antibiotics than actively respiring cells at the surface. This is part of why drainage is often necessary alongside antibiotics, and why researchers have begun exploring non-traditional strategies like anti-virulence compounds and immunomodulatory approaches to complement standard therapy.¹⁶

The pattern repeats across other infection sites. Urinary tract infections, pneumonia, wound infections, and bloodstream infections all present different oxygen environments, and Klebsiella adapts its metabolism to each one. That adaptability is not the only factor in its success as a pathogen, its capsule, siderophores, and antibiotic resistance genes all play important roles, but the ability to keep growing regardless of oxygen status is the metabolic foundation that everything else is built on.